Showing results (1-10 of 205) with videos related to
Sort By:
Pageof 21
Annual Review of Medicine|January 18, 2012
Role of endoplasmic reticulum stress in metabolic disease and other disordersLale Ozcan, Ira TabasNature|March 22, 2018
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistanceDevram S Ghorpade, Lale Ozcan, Ze Zheng, et al.Science Translational Medicine|June 6, 2014
Common therapeutic targets in cardiometabolic diseaseGabrielle Fredman, Lale Ozcan, Ira TabasCell Reports|May 31, 2016
Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin ResistanceLale Ozcan, Devram S Ghorpade, Ze Zheng, et al.The Journal of Cell Biology|December 8, 2010
NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosisGang Li, Christopher Scull, Lale Ozcan, et al.Diabetes|June 13, 2015
Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin SensitivityLale Ozcan, Xiaoming Xu, Shi-Xian Deng, et al.Plos One|August 29, 2015
Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in ObesityManikandan Subramanian, Lale Ozcan, Devram Sampat Ghorpade, et al.Proceedings of the National Academy of Sciences of the United States of America|September 24, 2014
Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathwayGabrielle Fredman, Lale Ozcan, Stefano Spolitu, et al.Cell Metabolism|November 26, 2013
Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signalingLale Ozcan, Jane Cristina de Souza, Alp Avi Harari, et al.Plos One|May 13, 2021
Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosisLale Ozcan, Canan Kasikara, Arif Yurdagul, et al.Pageof 21